X4 Pharmaceuticals
Financial ratios & Valuation

Forward Multiples (2025 – 2028)

2025202620272028
Price/Earnings ratio
-6.37-12.24-496.6833.11
Price/Sales ratio
1.530.740.410.35
Earnings per Share (EPS)
$-0.46$-0.24$-0.00$0.09

Historical Multiples (2015 – 2023)

2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-5.91-3.40-0.77-0.14-2.17-2.07-0.66-0.67-1.47-1.01-1.16
Price/Sales ratio
N/AN/AN/A1.82N/A43.03N/AN/AN/AN/A21.51
Price/Book Value ratio
-2.27-1.380.440.290.951.770.910.852.911.290.62
Price/Cash Flow ratio
-7.22-3.61-0.94-0.15-2.56-2.19-0.83-0.81-1.54-1.24-1.36
Price/Free Cash Flow ratio
-7.11-3.59-0.94-0.15-2.55-2.14-0.82-0.81-1.54-1.24-1.35
Price/Earnings Growth ratio
N/A-0.04-0.000.030.020.05-0.050.010.02-0.010.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/A97.05%N/A100%N/AN/AN/AN/A50%
Operating Profit Margin
N/AN/AN/A-1311%N/A-1995.79%N/AN/AN/AN/A-997.89%
Pretax Profit Margin
N/AN/AN/A-1229.17%N/A-2066.10%N/AN/AN/AN/A-1033.05%
Net Profit Margin
N/AN/AN/A-1229.17%N/A-2071.03%N/AN/AN/AN/A-1035.51%
Effective Tax Rate
-2.98%-11.39%-5.51%-9.07%-7.19%-0.23%-0.01%-0.02%-0.07%-0.02%-8.13%
Return on Assets
-138.99%-302.14%-41.69%-119.48%-35.22%-50.56%-75.69%-60.33%-68.70%-60.33%-42.89%
Return On Equity
38.51%40.61%-57.70%-199.17%-43.80%-85.34%-137.70%-126.75%-197.98%-174.07%-64.57%
Return on Capital Employed
-523.29%546.36%-49.11%-149.92%-34.18%-53.97%-82.50%-65.71%-86.43%-65.71%-44.08%
Liquidity Ratios
Current Ratio
N/AN/A7.446.4913.686.97N/AN/AN/A5.7610.32
Quick Ratio
1.250.3710.476.4913.686.976.265.765.335.4510.32
Cash ratio
1.010.259.995.6913.356.585.835.454.335.459.97
Days of Sales Outstanding
N/AN/AN/A298.15N/A111.56N/AN/AN/AN/A55.78
Days of Inventory outstanding
N/A1.51K664.48N/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
N/AN/AN/A298.15N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
385.982.00K3.54K1.93K1.13KN/A826.261.42K1.63KN/A567.05
Cash Conversion Cycle
N/AN/AN/A-1.63KN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.752.000.150.260.130.270.290.220.370.520.19
Debt Equity Ratio
-0.20-0.260.200.440.160.460.540.471.081.100.30
Long-term Debt to Capitalization
-0.15-0.210.140.260.130.310.330.300.510.320.20
Total Debt to Capitalization
-0.26-0.360.170.300.130.310.350.310.520.340.22
Interest Coverage Ratio
N/AN/A-15.51-41.10-22.26-22.27N/AN/AN/A-21.93-31.68
Cash Flow to Debt Ratio
-1.50-1.41-2.27-4.26-2.28-1.73-2.02-2.21-1.73-2.00-3.27
Company Equity Multiplier
-0.27-0.131.381.661.241.681.812.102.882.101.45
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/A-11.68N/A-19.60N/AN/AN/AN/A-9.80
Free Cash Flow / Operating Cash Flow Ratio
1.011.001.001.001.001.021.001.001.001.001.01
Cash Flow Coverage Ratio
-1.50-1.41-2.27-4.26-2.28-1.73-2.02-2.21-1.73-2.00-3.27
Short Term Coverage Ratio
-4.34-4.21-12.04-24.24-53.51-74.83-37.91-30.68-87.81-30.68-42.09
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A